These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7832261)

  • 1. Estimating the costs of substance abuse to the Medicaid hospital care program.
    Fox K; Merrill JC; Chang HH; Califano JA
    Am J Public Health; 1995 Jan; 85(1):48-54. PubMed ID: 7832261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The costs of alcohol, illegal drugs, and tobacco in Canada, 2002.
    Rehm J; Gnam W; Popova S; Baliunas D; Brochu S; Fischer B; Patra J; Sarnocinska-Hart A; Taylor B
    J Stud Alcohol Drugs; 2007 Nov; 68(6):886-95. PubMed ID: 17960307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicaid reimbursement of primary care providers for treatment of substance use disorders.
    Haack MR; Alemi FF
    Subst Abus; 2002 Sep; 23(3 Suppl):95-104. PubMed ID: 23580989
    [No Abstract]   [Full Text] [Related]  

  • 4. Expenditure effects of changes in Medicaid benefit coverage: an alcohol and substance abuse example.
    Reutzel TJ; Becker FW; Sanders BK
    Am J Public Health; 1987 Apr; 77(4):503-4. PubMed ID: 3548445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring comorbidity and overlap in the hospitalization cost for alcohol and drug abuse and mental illness.
    Rice DP; Kelman S
    Inquiry; 1989; 26(2):249-60. PubMed ID: 2526093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic costs of substance abuse, 1995.
    Rice DP
    Proc Assoc Am Physicians; 1999; 111(2):119-25. PubMed ID: 10220806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public spending for illegal drug and alcohol treatment in hospitals: an EU cross-country comparison.
    Lievens D; Vander Laenen F; Christiaens J
    Subst Abuse Treat Prev Policy; 2014 Jun; 9():26. PubMed ID: 24981850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the economic costs of the abuse of tobacco, alcohol and illicit drugs: a review of methodologies and Canadian data sources.
    Choi BC; Robson L; Single E
    Chronic Dis Can; 1997; 18(4):149-65. PubMed ID: 9445363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State estimates of Medicaid expenditures attributable to cigarette smoking, fiscal year 1993.
    Miller LS; Zhang X; Novotny T; Rice DP; Max W
    Public Health Rep; 1998; 113(2):140-51. PubMed ID: 9719815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical care use by treated and untreated substance abusing medicaid patients.
    Gerson LW; Boex J; Hua K; Liebelt RA; Zumbar WR; Bush D; Givens C
    J Subst Abuse Treat; 2001 Mar; 20(2):115-20. PubMed ID: 11306213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of substance disorders on medical expenditures for medicaid beneficiaries with behavioral health disorders.
    Clark RE; Samnaliev M; McGovern MP
    Psychiatr Serv; 2009 Jan; 60(1):35-42. PubMed ID: 19114568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical-care expenditures attributable to cigarette smoking during pregnancy -- United States, 1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Nov; 46(44):1048-50. PubMed ID: 9370226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs of alcohol and drug abuse in the United States, 1992. Alcohol/Drugs COI Study Team.
    Holland P; Mushinski M
    Stat Bull Metrop Insur Co; 1999; 80(4):2-9. PubMed ID: 10553265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatric care.
    Dickey B; Azeni H
    Am J Public Health; 1996 Jul; 86(7):973-7. PubMed ID: 8669521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financing and payment reform for primary health care and substance abuse treatment.
    Kunnes R; Niven R; Gustafson T; Brooks N; Levin SM; Edmunds M; Trumble JG; Coye MJ
    J Addict Dis; 1993; 12(2):23-42. PubMed ID: 8386551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicaid support of alcohol, drug abuse, and mental health services.
    Wright GE; Buck JA
    Health Care Financ Rev; 1991; 13(1):117-28. PubMed ID: 10170864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
    Fleming E; Lien H; Ma CT; McGuire TG
    J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining the "cost" of substance abuse in pregnancy: patient outcomes and resource utilization.
    Stichler JF; Weiss M; Wight NE
    J Perinatol; 1998; 18(5):384-8. PubMed ID: 9766417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical content of preconception care: alcohol, tobacco, and illicit drug exposures.
    Floyd RL; Jack BW; Cefalo R; Atrash H; Mahoney J; Herron A; Husten C; Sokol RJ
    Am J Obstet Gynecol; 2008 Dec; 199(6 Suppl 2):S333-9. PubMed ID: 19081427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychotropic drug use and expenditures among medicaid beneficiaries with and without other mental health or substance abuse services.
    Hennessy KD; Green-Hennessy S; Buck JA; Miller K
    J Nerv Ment Dis; 2003 Jul; 191(7):476-8. PubMed ID: 12891096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.